Literature DB >> 10327052

Metastasis-association of the rat ortholog of the human epithelial glycoprotein antigen EGP314.

J Würfel1, M Rösel, S Seiter, C Claas, M Herlevsen, R Weth, M Zöller.   

Abstract

Screening for surface molecules expressed by metastasizing rat tumors had revealed evidence for metastasis-association of a molecule also expressed on epithelial cells. The similarity to the expression profile of the panepithelial glycoprotein EGP314 prompted us to isolate and sequence the gene and to explore functional features of the molecule in transfected tumor lines. The molecule D5.7A, named according to the antibody, D5.7, used for selection, indeed, is the ortholog of EGP314 with 92% and 80% identity to the murine and the human molecules. Like EGP314, D5.7A has a particular cleavage site, a small cleavage product being resolved under reducing conditions from the membrane anchored part of the molecule. Transfection of a low metastasizing fibrosarcoma, pheochromoblastoma and adenocarcinoma revealed that expression of D5.7A facilitates tumor progression. Depending on the origin of the tumor, D5.7A transfectants either metastasized via the lymphatic system (pheochromoblastoma, adenocarcinoma) or hematogeneously (fibrosarcoma). Particularly after proteolytic cleavage, D5.7A facilitated cell - cell adhesion and provided a proliferative signal upon crosslinking. Thus, the rat ortholog of EGP314 is involved in metastasis formation. Importantly, its functional activities apparently rely on proteolytic cleavage. These findings provide a first evidence on how a panepithelial marker can be involved in tumor progression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10327052     DOI: 10.1038/sj.onc.1202542

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

1.  Profile of estrogen-responsive genes in an estrogen-specific mammary gland outgrowth model.

Authors:  Bonnie J Deroo; Sylvia C Hewitt; Jennifer B Collins; Sherry F Grissom; Katherine J Hamilton; Kenneth S Korach
Journal:  Mol Reprod Dev       Date:  2009-08       Impact factor: 2.609

2.  Gene expression analysis in Interleukin-12-induced suppression of mouse mammary carcinoma.

Authors:  Xiaoyan Shi; Jianguo Liu; Zhaoying Xiang; Maki Mitsuhashi; Rita S Wu; Xiaojing Ma
Journal:  Int J Cancer       Date:  2004-07-01       Impact factor: 7.396

Review 3.  Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule.

Authors:  Monika Trzpis; Pamela M J McLaughlin; Lou M F H de Leij; Martin C Harmsen
Journal:  Am J Pathol       Date:  2007-06-28       Impact factor: 4.307

4.  EPCAM mutation update: Variants associated with congenital tufting enteropathy and Lynch syndrome.

Authors:  Sagar J Pathak; James L Mueller; Kevin Okamoto; Barun Das; Jozef Hertecant; Lynn Greenhalgh; Trevor Cole; Vered Pinsk; Baruch Yerushalmi; Odul E Gurkan; Michael Yourshaw; Erick Hernandez; Sandy Oesterreicher; Sandhia Naik; Ian R Sanderson; Irene Axelsson; Daniel Agardh; C Richard Boland; Martin G Martin; Christopher D Putnam; Mamata Sivagnanam
Journal:  Hum Mutat       Date:  2018-11-29       Impact factor: 4.878

Review 5.  Ping-Pong-Tumor and Host in Pancreatic Cancer Progression.

Authors:  Wei Mu; Zhe Wang; Margot Zöller
Journal:  Front Oncol       Date:  2019-12-16       Impact factor: 6.244

6.  The epithelial cell adhesion molecule EpCAM is required for epithelial morphogenesis and integrity during zebrafish epiboly and skin development.

Authors:  Krasimir Slanchev; Thomas J Carney; Marc P Stemmler; Birgit Koschorz; Adam Amsterdam; Heinz Schwarz; Matthias Hammerschmidt
Journal:  PLoS Genet       Date:  2009-07-17       Impact factor: 5.917

7.  A genome-wide expression analysis identifies a network of EpCAM-induced cell cycle regulators.

Authors:  K Maaser; J Borlak
Journal:  Br J Cancer       Date:  2008-10-28       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.